You are here

Forum

sandy craine on 23 October 2009

Category: Uncategorised

Replies: 0

Last updated: 23 October 2009

ECPC masterclass- Munich
by sandy craine (Oct 23)

I will be attending this years ECPC Masterclass in Munich over this weekend and then presenting at the EPOSSI 10th workshop on Rare Cancers in Brussels on Monday and Tuesday so I might not be able
Category: Uncategorised

Replies: 0

Last updated: 23 October 2009
sandy craine on 20 October 2009

Category: Uncategorised

Replies: 0

Last updated: 20 October 2009

Cancer Therapy and Infection: take part in a survey
by sandy craine (Oct 20)

Cancer Therapy and Infection: Assessing knowledge and current practices in preventing and managing infections during chemotherapy treatment
PatientView is conducting a new patient survey focusing on
Category: Uncategorised

Replies: 0

Last updated: 20 October 2009
Don Adkins on 18 October 2009

Category: Uncategorised

Replies: 0

Last updated: 18 October 2009

Phase III Dasatinib Trial
by Don Adkins (Oct 18)

Hi Everyone,
I found this article in the LLS news letter. Thought you might find it interesting.
Don
Kantarjian H, Cortes J, Kim DW, Dorlhiac-Llacer P, Pasquini R, DiPersio J, Müller MC, Radich JP
Category: Uncategorised

Replies: 0

Last updated: 18 October 2009
zaviemiller on 12 October 2009

Category: Uncategorised

Replies: 0

Last updated: 12 October 2009

Welma
by zaviemiller (Oct 12)

Hi Welma,
I received your email and tried to repond. Your server rejected my email (welmap@daff.gov.za). Could you please contact me using a different email address or allow my address to get
Category: Uncategorised

Replies: 0

Last updated: 12 October 2009
pratik on 28 September 2009

Category: Uncategorised

Replies: 0

Last updated: 28 September 2009

Search engine optimization
by pratik (Sep 28)

SEO Company India
SEO company in India offers Search engine optimization (SEO) services world wide. SEO experts are purely professional and understand client value. SEO Experts are well qualified
Category: Uncategorised

Replies: 0

Last updated: 28 September 2009
Sneezy123 on 20 September 2009

Category: Uncategorised

Replies: 0

Last updated: 20 September 2009

Resveratrol
by Sneezy123 (Sep 20)

Is there any evidence that reservatrol has a beneficial or adverse effect on CML or Gleevec treatment? ( No anecdotal or non-scientific comments, please ). Thanks, Frank
Category: Uncategorised

Replies: 0

Last updated: 20 September 2009
pat preston on 15 September 2009

Category: Uncategorised

Replies: 0

Last updated: 15 September 2009

Once again from 'The Old Timer Pat'
by pat preston (Sep 15)

Dear Sandy, David, Pennie, Phil and Val (and everyone else who may read this). It did my old heart good to hear from you and many thanks for that.
I was at Nottingham City Hospital yesterday for my
Category: Uncategorised

Replies: 0

Last updated: 15 September 2009
sandy craine on 14 August 2009

Category: Uncategorised

Replies: 0

Last updated: 14 August 2009

Bcr/Abl kinase domain mutations and drug resistance. -Traffic light chart plus PDF link to full article
by sandy craine (Aug 14)

Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukaemia

Thomas O’Hare,1,2 Christopher A. Eide,2 and Michael W. N. Deininger2 1Howard
Category: Uncategorised

Replies: 0

Last updated: 14 August 2009
sandy craine on 13 August 2009

Category: Uncategorised

Replies: 0

Last updated: 13 August 2009

Sign the UICC World Cancer Declaration
by sandy craine (Aug 13)

Please add your support by signing the World Cancer Declaration today!

Aug 9 2009
The time is ripe for cancer care to become a global priority. The Max Foundation, help CML patients who do
Category: Uncategorised

Replies: 0

Last updated: 13 August 2009
Steven D on 31 July 2009

Category: Uncategorised

Replies: 0

Last updated: 31 July 2009

NEWS FLASH> Annual CML Seminar on 14th November in Nottingham
by Steven D (Jul 31)

Hi

Have just herts the date for the annual seminar in Nottingahm will be the 14th November. I will update as and when I hear unless I am beaten to it by someone else. Steven D.
Category: Uncategorised

Replies: 0

Last updated: 31 July 2009
sandy craine on 17 July 2009

Category: Uncategorised

Replies: 0

Last updated: 17 July 2009

Cutting-edge drugs to be fast-tracked, bypassing NICE
by sandy craine (Jul 17)

Cutting-edge drugs to be fast-tracked, bypassing NICE

15 July 2009

The UK government has announced plans to allow highly innovative drugs to be made available on the NHS for a limited
Category: Uncategorised

Replies: 0

Last updated: 17 July 2009
sandy craine on 10 July 2009

Category: Uncategorised

Replies: 0

Last updated: 10 July 2009

Please sign the call for action against rare cancers!
by sandy craine (Jul 10)

There are a little over 230 signatures for the call to action campaign to date.
I would like to ask all members who access this site to PLEASE sign this important petition.
The CML Support Group is
Category: Uncategorised

Replies: 0

Last updated: 10 July 2009
chattena on 7 July 2009

Category: Uncategorised

Replies: 0

Last updated: 7 July 2009

Yorkshire Chronic Myeloid Leukaemia Support Group Success!!
by chattena (Jul 7)

A Big thank you to everybody who attended the support group held on the 6th July in Leeds. I think it generated a lot of usefull discussion.

The next meeting is proposed for September 14th 7pm
Category: Uncategorised

Replies: 0

Last updated: 7 July 2009
sal on 19 June 2009

Category: Uncategorised

Replies: 0

Last updated: 19 June 2009

1st PCR on Nilotinib
by sal (Jun 19)

Rob has now been on Nilotinib for 12 weeks and his Pcr is 1.8 his last PCR on Dasatinib six months ago was 0.4 however he was off treatment altogether for about four months while we waited for the
Category: Uncategorised

Replies: 0

Last updated: 19 June 2009
sandy craine on 9 June 2009

Category: Uncategorised

Replies: 0

Last updated: 9 June 2009

IFN-? wakes up sleeping hematopoietic stem cells -
by sandy craine (Jun 9)

Persistent CML-initiating cells, or CML stem cells, which are protected from imatinib killing by their quiescent status, are

probably responsible for the regrowth of the disease.
See under
Category: Uncategorised

Replies: 0

Last updated: 9 June 2009
david barnes on 3 June 2009

Category: Uncategorised

Replies: 0

Last updated: 3 June 2009

manchester/blackpool bike ride
by david barnes (Jun 3)

I am takeing part in this ride and hope to raise some money for christies hospital and just wonderd if anyone else who suffers from CML is entering
Category: Uncategorised

Replies: 0

Last updated: 3 June 2009
sandy craine on 1 June 2009

Category: Uncategorised

Replies: 0

Last updated: 1 June 2009

Tasigna 'users'
by sandy craine (Jun 1)

I would like to hear from UK patients who are being treated with Tasigna and who would be interested in attending a 'round table' disussion about the experience.
I believe there are up to 3 places
Category: Uncategorised

Replies: 0

Last updated: 1 June 2009
sandy craine on 1 June 2009

Category: Uncategorised

Replies: 0

Last updated: 1 June 2009

ASCO 2009
by sandy craine (Jun 1)

For all those who are interested I have put links to ASCO 2009 abstracts that are relevant to CML on the Seminars and Conferences page - link on main menu then click on 'other conferences'
I have
Category: Uncategorised

Replies: 0

Last updated: 1 June 2009
chattena on 27 May 2009

Category: Uncategorised

Replies: 0

Last updated: 27 May 2009

Yorkshire Cancer Network CML support group
by chattena (May 27)

CML support group intitial meeting is on the 6th July , Level 7 Bexley Wing St James, Leeds. 7pm until 9pm with refreshments. Dr GM Smith will be talking. For further information ring Alison Chatten
Category: Uncategorised

Replies: 0

Last updated: 27 May 2009
sandy craine on 17 May 2009

Category: Uncategorised

Replies: 0

Last updated: 17 May 2009

Interim analysis of the STIM trial. STopIMatinib
by sandy craine (May 17)

The following will be presented at ASCO
Sandy
Persistence of complete molecular remission in chronic myeloid leukemia after imatinib discontinuation: Interim analysis of the STIM trial.
Author(s): F
Category: Uncategorised

Replies: 0

Last updated: 17 May 2009